Claim Evidence review

Anaptys will report initial Phase 2 ulcerative colitis (UC) data for ro...

Daniel Faga: Anaptys will report initial Phase 2 ulcerative colitis (UC) data for rosnilimab. Published May 5, 2025. Status: Evidence review. This stored outco...

  • Actor: Daniel Faga
  • Topic: Science
  • Status: Evidence review
  • Published: May 5, 2025
  • Deadline: Dec 31, 2025
Anaptys will report initial Phase 2 ulcerative colitis (UC) data for rosnilimab.

FactTracker assessment

This stored outcome is excluded from public accuracy until auditable verification evidence is available.

Verification rule: Event occurs: Anaptys will report initial Phase 2 ulcerative colitis (UC) data for rosnilimab.; window 2025-05-05 to 2025-12-31

Original source: ir.anaptysbio.com